Literature DB >> 8381825

Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption.

X Q Li1, V Tembe, G M Horwitz, D A Bushinsky, M J Favus.   

Abstract

In humans, familial or idiopathic hypercalciuria (IH) is a common cause of hypercalciuria and predisposes to calcium oxalate nephrolithiasis. Intestinal calcium hyperabsorption is a constant feature of IH and may be due to either a vitamin D-independent process in the intestine, a primary overproduction of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], or a defect in renal tubular calcium reabsorption. Selective breeding of spontaneously hypercalciuric male and female Sprague-Dawley rats resulted in offspring with hypercalciuria, increased intestinal calcium absorption, and normal serum 1,25(OH)2D3 levels. The role of the vitamin D receptor (VDR) in the regulation of intestinal calcium absorption was explored in 10th generation male genetic IH rats and normocalciuric controls. Urine calcium excretion was greater in IH rats than controls (2.9 +/- 0.3 vs. 0.7 +/- 0.2 mg/24 h, P < 0.001). IH rat intestine contained twice the abundance of VDR compared with normocalciuric controls (536 +/- 73 vs. 243 +/- 42 nmol/mg protein, P < 0.001), with no difference in the affinity of the receptor for its ligand. Comparable migration of IH and normal intestinal VDR on Western blots and of intestinal VDR mRNA by Northern analysis suggests that the VDR in IH rat intestine is not due to large deletion or addition mutations of the wild-type VDR. IH rat intestine contained greater concentrations of vitamin D-dependent calbindin 9-kD protein. The present studies strongly suggest that increased intestinal VDR number and normal levels of circulating 1,25(OH)2D3 result in increased functional VDR-1,25(OH)2D3 complexes, which exert biological actions in enterocytes to increase intestinal calcium transport. Intestinal calcium hyperabsorption in the IH rat may be the first example of a genetic disorder resulting from a pathologic increase in VDR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381825      PMCID: PMC288005          DOI: 10.1172/JCI116246

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

Authors:  R A Kaplan; M R Haussler; L J Deftos; H Bone; C Y Pak
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

2.  Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria.

Authors:  F H Shen; D J Baylink; R L Nielsen; D J Sherrard; J L Ivey; M R Haussler
Journal:  J Lab Clin Med       Date:  1977-12

3.  Gastrointestinal calcium absorption in nephrolithiasis.

Authors:  C Y Pak; D A East; L J Sanzenbacher; C S Delea; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

4.  The distribution of urinary calcium excretions in normal persons and stone-formers.

Authors:  W G Robertson; D B Morgan
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

5.  Characterization of a cytoplasmic receptor-like binder for 1 alpha, 25-dihydroxycholecalciferol in rat intestinal mucosa.

Authors:  D Feldman; T A McCain; M A Hirst; T L Chen; K W Colston
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

6.  Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate.

Authors:  C Y Pak; O Waters; L Arnold; K Holt; C Cox; D Barilla
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

7.  Urinary saturation measurements in calcium nephrolithiasis.

Authors:  D V Weber; F L Coe; J H Parks; M S Dunn; V Tembe
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

8.  Familial idiopathic hypercalciuria.

Authors:  F L Coe; J H Parks; E S Moore
Journal:  N Engl J Med       Date:  1979-02-15       Impact factor: 91.245

9.  Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias.

Authors:  J E Zerwekh; C Y Pak
Journal:  Metabolism       Date:  1980-01       Impact factor: 8.694

10.  Placental calcium binding protein in rats. Apparent identity with vitamin D-dependent calcium binding protein from rat intestine.

Authors:  M E Bruns; A Fausto; L V Avioli
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

View more
  34 in total

1.  Nephrolithiasis: site of the initial solid phase.

Authors:  David A Bushinsky
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Bone disease in pediatric idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2012-04-06

3.  Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.

Authors:  Viviane Barcellos Menon; Rosa Maria Affonso Moysés; Samirah Abreu Gomes; Aluizio Barbosa de Carvalho; Vanda Jorgetti; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

4.  Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.

Authors:  J Yao; P Kathpalia; D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; John R Asplin; Ignacio Granja; Felix M Ramos; Courtney Flotteron; Luojing Chen; Tong Tong Wu; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 10.121

Review 6.  Idiopathic hypercalciuria and bone health.

Authors:  Laura E Ryan; Steven W Ing
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

7.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

8.  Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Christopher D Culbertson; Ignacio Granja; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

Review 9.  New insights into the pathogenesis of idiopathic hypercalciuria.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

10.  Vitamin D receptor gene polymorphism in hypercalciuric children.

Authors:  Oğuz Söylemezoğlu; Ozan Ozkaya; Sevim Gönen; Müge Misirlioğlu; Süleyman Kalman; Necla Buyan
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.